Bronchial epithelial cell DNA

Bronchial epithelial cell DNA refers to the genomic material within the cells lining the bronchial passages of the lungs. This DNA serves as the blueprint for cellular function and is a critical site for pathological alterations, particularly those induced by inhaled carcinogens such as tobacco smoke and environmental pollutants, which lead to the formation of DNA adducts and subsequent oncogenic mutations (e.g., in KRAS or TP53) [1]. In the context of therapeutic intervention, this DNA is the primary target for gene therapies aiming to correct genetic disorders like cystic fibrosis by delivering functional CFTR gene sequences directly to the airway epithelium [2]. Additionally, it is the molecular target for various cytotoxic chemotherapies, such as platinum-based agents, which exert their effect by inducing DNA cross-linking and apoptosis in malignant bronchial cells [3]. Despite its importance, the term is often considered a broad anatomical/molecular site rather than a specific protein target, presenting challenges in achieving cell-specific precision without affecting systemic genomic integrity.

Other names

Airway epithelial DNALung epithelial DNABronchial DNA

DNA alkylation, DNA cross-linking, Gene addition/replacement, Gene editing (CRISPR/Cas9), Inhibition of DNA synthesis